StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.90+0.19 (+5.12%)

Close on Nov 16, 2026Market cap $162.23MP/E 0.9Yield 6.41%

Oramed Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Oramed Pharmaceuticals's ebitda for the twelve months ending May 31, 2015 was -$15.37M. For fiscal 2014 it was -$5.90M, down 236.9% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2014Aug 31, 2014-$5.90M-236.9%
FY2013Aug 31, 2013$4.31M–
FY2012Aug 31, 2012-$2.87M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2016CQ2 2016May 31, 2016$2.11M–
Q2 FY2016CQ1 2016Feb 29, 2016-$1.91M–
Q1 FY2016CQ4 2015Nov 30, 2015$2.45M–
Q3 FY2015CQ2 2015May 31, 2015-$1.63M–
Q2 FY2015CQ1 2015Feb 28, 2015-$1.67M–

More Oramed Pharmaceuticals figures

See a number that looks wrong?